Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What Will Novartis Do With $13bn Cash Pile From GSK?

Mar 27 2018

• By Kevin Grogan

Money — More money for Novartis' warchest • Source: Shutterstock

Related Content

Roche To Improve Real-World Cancer Data Extraction With Flatiron Buy

Feb 21 2018

Interview: Sandoz CEO On Biosimilars And Reshaping US Business

Jan 25 2018

Lutathera Approval Positions Novartis To Regain NET Share Taken By Ipsen

Jan 29 2018

Novartis Sale Of US Oral Generics Unit Seems Unlikely

Feb 19 2018

Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact

Mar 01 2018

Digital Gets Top Billing As Novartis CEO Wields Management Broom

Mar 12 2018

GSK Exercises Right To Buy Out Novartis Consumer Healthcare JV For $13bn

Mar 27 2018

Related Companies

Novartis AG

GSK plc

Pear Therapeutics, Inc.

Roche Holding AG

Roche Holding AG

Additional Topics

M & A Business Strategies Deals Commercial Consumer BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window